SCHEMBL28016406

SCHEMBL28016406

Nc1ncc2ncn(I)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
ADRA1A P35348 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
HDAC6 Q9UBN7 2/20 0.40
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
ROCK1 Q13464 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
IRAK4 Q9NWZ3 2/20 0.32
CDK4 P11802 1/20 0.32
CCND3 P30281 1/20 0.32
MET P08581 1/20 0.31
FGFR1 P11362 2/20 0.31
FGFR2 P21802 2/20 0.31
FGFR4 P22455 2/20 0.31
FGFR3 P22607 2/20 0.31
EGFR P00533 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2983374 0.80 DYRK1A (0.46) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL27303515 0.78 HDAC6 (0.40) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL3144585 0.76 HDAC6 (0.40) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL5034216 0.76 HDAC6 (0.40) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL27944268 0.76 HSP90AA1 (0.41) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL5942179 0.76 HDAC6 (0.43) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL27641128 0.74 KDM4E (0.41) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL24453428 0.73 HDAC6 (0.41) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL3157542 0.73 HSD17B10 (0.52) KDM4EALDH1A1HPGDADRA1AHSD17B10
SCHEMBL14010824 0.73 KDM4E (0.55) KDM4EALDH1A1HPGDADRA1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104788485-B The method for preparing antiviral agent 百时美-施贵宝爱尔兰控股公司 2017-10-03 CN disclosed
CN-104788485-A Process for preparing antiviral agent BRISTOL MYERS SQUIBB CO 2015-07-22 CN disclosed
CN-102675355-B Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one BRISTOL MYERS SQUIBB CO 2015-05-06 CN disclosed